Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
- Resource Type
- Article
- Source
- The Lancet; July 2021, Vol. 398 Issue: 10295 p121-130, 10p
- Subject
- Language
- ISSN
- 01406736; 1474547X